Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation-Reference-Cited by-同舟云学术

Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation

Published:2016-09 Issue: Volume:38 Page:324-331
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Liu Xingkai,Wang Tuo,Liu Xueshibojie,Cai Lu,Qi Jun,Zhang Ping,Li Yan

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference29 articles.

1. Dialytic treatment of rhabdomyolysis-induced acute renal failure: our experience;Splendiani;Ren. Fail.,2001

2. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. (vol 129, pg 512, 2005);Andrade;Gastroenterology,2005

3. Role of oxidative stress in alcohol-induced liver injury;Cederbaum;Arch. Toxicol.,2009

4. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury;Davern;Gastroenterology,2011

5. Curcumin attenuates d-galactosamine/lipopolysaccharide-induced liver injury and mitochondrial dysfunction in mice;Zhang;J. Nutr.,2014

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Therapeutic Potentials of Biochanin A in Neurological Disorders: Pharmacokinetic and Pharmacodynamic Overview;Chemistry & Biodiversity;2024-07-16

2. Biochanin A inhibits excitotoxicity-triggered ferroptosis by targeting GPX4 in hippocampal neurons;2024-03-18

3. Oxymatrine mitigates Aspergillus fumigatus keratitis by suppressing fungal activity and restricting pyroptosis;Experimental Eye Research;2024-03

4. Evaluating the Role of Biochanin A in Acetic acid-Induced Colitis in Rats: Involvement of Nitric Oxide Pathway;RES J PHARMACOGN;2024

5. Nrf2: A promising therapeutic target in bone-related diseases;Biomedicine & Pharmacotherapy;2023-12